Insights


Key Advances in Endometrial Cancer

January 29th 2021

Treatment Approach in Advanced Melanoma

January 8th 2021

BCMA as a Target in Heavily Pre-Treated RRMM

December 18th 2020

Modern Perspectives in Advanced Melanoma

December 14th 2020

Emerging Strategies for Renal Cell Carcinoma

December 14th 2020

Treating Advanced RAI-Refractory DTC: A Two-Way Street: Medical Oncology and Endocrinology

December 14th 2020

Treatment Options in Metastatic Renal Cell Carcinoma

December 11th 2020

Contemporary Management of CLL

December 4th 2020

Treatment Options in Chronic Lymphocytic Leukemia: A Global Perspective

December 4th 2020

Treatment Options in Myelodysplastic Syndromes

November 18th 2020

Major Advances in RET Inhibition for NSCLC and MTC

November 16th 2020

Recent Developments in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

November 6th 2020

Considerations of Adjuvant Therapy in EGFR+ ES-NSCLC

October 20th 2020

First Results of the Phase 3 CheckMate 9ER Trial

October 15th 2020

Key Updates in Melanoma from ESMO 2020

October 12th 2020

EGFR-Mutated NSCLC: Are Frontline Combinations the Future?

September 29th 2020

The Impact of Chemotherapy-Induced Myelosuppression

September 16th 2020

Improving Survival in Metastatic Urothelial Cancer

August 26th 2020

Metastatic NSCLC: Recent Developments on ALK, ROS1, and NTRK

August 17th 2020

Improving Management of Relapsed/Refractory Multiple Myeloma

August 10th 2020